decemb
outbreak
sever
respiratori
viral
ill
first
identifi
hubei
provinc
china
ill
later
discov
caus
infect
novel
coronaviru
known
sever
acut
respiratori
syndrom
coronaviru
best
knowledg
present
first
confirm
case
patient
left
ventricular
assist
devic
lvad
support
case
patient
man
histori
endstag
ischem
cardiomyopathi
heartmat
ii
abbott
laboratori
abbott
park
il
lvad
destin
therapi
hypertens
atrial
flutter
ischem
stroke
present
fourday
histori
fever
cough
short
breath
follow
recent
twomonth
travel
egypt
initi
physic
examin
reveal
bodi
temperatur
degre
fahrenheit
degre
celsiu
normal
mean
arteri
pressur
doppler
oxygen
satur
room
air
arteri
blood
ga
reveal
pao
mmhg
despit
deliveri
fio
via
nonrebreath
ventil
lvad
paramet
stabl
present
chest
radiograph
show
bilater
pulmonari
infiltr
suggest
multifoc
pneumonia
figur
patient
appear
moder
respiratori
distress
tachypnea
accessori
muscl
use
due
concern
develop
respiratori
muscl
fatigu
impend
respiratori
failur
decis
made
pursu
intub
mechan
ventil
test
novel
coronaviru
return
posit
pcr
salient
featur
patient
initi
clinic
laboratori
trend
includ
lymphocytopenia
transamin
hyperbilirubinemia
elev
creatinin
lactat
dehydrogenas
ddimer
ferritin
level
follow
day
patient
develop
progress
hypotens
requir
initi
vasopressor
agent
acut
oligur
renal
failur
requir
continu
renal
replac
therapi
refractori
hypoxemia
consist
acut
respiratori
distress
syndrom
ard
right
ventricular
failur
consid
potenti
etiolog
hypotens
set
lvad
inflammatori
surg
patient
unabl
transfer
catheter
laboratori
invas
hemodynam
assess
due
pulmonari
arteri
catheter
attempt
bedsid
placement
unsuccess
central
line
util
measur
central
venou
pressur
mmhg
oxygen
satur
scvo
transthorac
echocardiogram
reveal
baselin
moder
right
ventricular
dysfunct
lvad
paramet
otherwis
remain
stabl
manag
ard
complic
refractori
hypoxemia
despit
mechan
ventil
implement
prone
posit
consid
assist
oxygen
howev
presenc
lvad
determin
rel
contraind
previous
shown
prone
posit
unload
right
ventricl
ard
due
improv
pulmonari
pressur
use
maneuv
set
lvad
well
describ
may
advers
associ
increas
rv
pressur
subsequ
rv
failur
patient
clinic
cours
later
complic
septic
shock
set
escherichia
coli
lactobacillu
speci
bacteremia
hyperbilirubinemia
secondari
acalcul
cholecyst
requir
percutan
cholecystostomi
acut
blood
loss
anemia
secondari
gastrointestin
bleed
requir
blood
transfus
due
prolong
ventil
depend
respiratori
failur
patient
underw
placement
tracheostomi
patient
treat
hydroxychloroquin
mg
twice
daili
follow
initi
diagnosi
oseltamivir
mg
twice
daili
ad
liquid
lopinavirritonavir
avail
institut
patient
switch
lopinavirritonavir
mg
twice
daili
treatment
day
discontinu
set
hyperbilirubinemia
treatment
day
transit
back
hydroxychloroquin
mg
twice
daili
complet
total
fourteenday
cours
patient
deem
candid
compassion
use
remdesivir
due
poor
creatinin
clearanc
report
describ
first
known
present
ill
secondari
patient
longterm
lvad
support
time
write
patient
remain
critic
ill
howev
clinic
improv
recent
evid
suggest
patient
cardiovascular
comorbid
appear
increas
risk
morbid
mortal
notabl
prior
studi
shown
cellular
immun
compromis
among
longterm
lvad
recipi
function
immunocompromis
state
may
part
explain
patient
rapid
clinic
deterior
prolong
critic
ill
follow
infect
increas
suscept
viral
infect
particularli
set
lvad
report
previous
literatur
furthermor
case
highlight
import
consider
manag
ard
safeti
efficaci
prone
posit
presenc
lvad
current
unknown
final
propos
establish
covidlvad
registri
understand
impact
advanc
heart
failur
popul
